购物车

全部删除
您的购物车当前为空

前往下单页继续购物

VEGF165 Protein, Human/Cynomolgus, Recombinant V2

一键复制产品信息

产品编号 TMPY-01041U

VEGF165 Protein, Human/Cynomolgus, Recombinant V2 is expressed in HEK293 Cells. The accession number is P15692-4.

VEGF165 Protein, Human/Cynomolgus, Recombinant V2

一键复制产品信息

产品编号 TMPY-01041U

VEGF165 Protein, Human/Cynomolgus, Recombinant V2 is expressed in HEK293 Cells. The accession number is P15692-4.

规格	价格	库存	数量

大包装 & 定制

TargetMol 的所有产品仅用作科学研究或药证申报，不能被用于人体，我们不向个人提供产品和服务。请您遵守承诺用途，不得违反法律法规规定用于任何其他用途。

实验操作小课堂

常见问题解答

资源下载

重组蛋白用户指南

产品信息

生物活性	Immobilized Human VEGF165 at 1 μg/ml (100 μl/well) on the plate. Dose response curve for Human VEGFR2, mFc Tag with the EC50 of 42.3 ng/ml determined by ELISA. Human VEGF165 stimulates proliferation of human umbilical vein endothelial cells (HUVEC) with the ED50 for this effect is 2.57 ng/mL (QC Test).
产品描述	VEGF165 Protein, Human/Cynomolgus, Recombinant V2 is expressed in HEK293 Cells. The accession number is P15692-4.
种属	Human
表达系统	HEK293 Cells
标签	Tag Free
蛋白编号	P15692-4
别名	VPF,VEGFA,VEGF,Vascular permeability factor,L-VEGF
蛋白构建	Ala27-Arg191
蛋白纯度	> 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC
分子量	19.2 kDa (Predicted); 20-30 kDa (Due to glycosylation)
内毒素	< 1.0 EU/μg of the protein as determined by the LAL method.
蛋白性状	Lyophilized powder
缓冲液	Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
存储	Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots.
运输方式	In general, Lyophilized powders are shipping with blue ice. Solutions are shipping with dry ice.
研究背景	Human papillomavirus (HPV) infection is an established risk factor for cervical carcinogenesis. VEGF165 was significantly higher, whereas VEGFC and VEGFD were significantly lower in malignant cervical carcinoma tissues as compared to normal cervix tissues. Expression levels of VEGF121 and VEGFC were significantly associated with type of tumor growth while VEGF165 was significantly associated with lymph node metastasis.